Volume 92, Issue 2, Pages (August 2017)

Slides:



Advertisements
Similar presentations
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 77, Issue 12, Pages (June 2010)
Volume 69, Issue 11, Pages (June 2006)
Intensive hemodialysis—keeping the faith
Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.
Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)
Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study 
Anemia management in chronic kidney disease
Volume 63, Issue 1, Pages (January 2003)
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)  Issa Al.
Volume 68, Issue 2, Pages (August 2005)
Intensive hemodialysis—keeping the faith
Volume 74, Issue 5, Pages (September 2008)
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Volume 87, Issue 5, Pages (May 2015)
Volume 78, Pages S41-S45 (August 2010)
Volume 84, Issue 3, Pages (September 2013)
Volume 87, Issue 1, Pages (January 2015)
Volume 85, Issue 1, Pages (January 2014)
Volume 88, Issue 2, Pages (August 2015)
Volume 94, Issue 3, Pages (September 2018)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Volume 68, Issue 6, Pages (December 2005)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 81, Issue 11, Pages (June 2012)
Comorbidity and confounding in end-stage renal disease
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Volume 77, Issue 7, Pages (April 2010)
Volume 82, Issue 5, Pages (September 2012)
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
U-shaped effect of eGFR and mortality
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS)  Michelle.
Body size and outcomes on peritoneal dialysis in the United States
Volume 64, Issue 5, Pages (November 2003)
Volume 67, Issue 3, Pages (March 2005)
Volume 85, Issue 1, Pages (January 2014)
Blood pressure targets in hemodialysis patients
The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder.
Volume 76, Issue 3, Pages (August 2009)
Volume 66, Issue 5, Pages (November 2004)
Volume 70, Issue 10, Pages (November 2006)
Volume 79, Issue 3, Pages (February 2011)
Volume 83, Issue 2, Pages (February 2013)
Cardiovascular disease in pediatric chronic dialysis patients
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Volume 64, Issue 1, Pages (July 2003)
Volume 68, Issue 1, Pages (July 2005)
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients  Finnian R. Mc Causland, Sushrut S.
Volume 63, Issue 6, Pages (June 2003)
Volume 95, Issue 4, Pages (April 2019)
Volume 60, Issue 3, Pages (September 2001)
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
Volume 61, Issue 1, Pages (January 2002)
Adynamic bone disease: a 14-year case report
American Journal of Kidney Diseases
Charles A. Herzog  Kidney International 
Volume 63, Pages S13-S16 (February 2003)
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 61, Issue 2, Pages (February 2002)
Volume 77, Issue 12, Pages (June 2010)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.
Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.
Risk of mortality in patients with diabetes and ESRD
Survival among hemodialysis patients by geographic region in DOPPS 3 (2005–2008), with and without adjustments for patient mix differences. Survival among.
Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.
Presentation transcript:

Volume 92, Issue 2, Pages 497-503 (August 2017) Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients  Junichi Hoshino, Maria Larkina, Angelo Karaboyas, Brian A. Bieber, Yoshifumi Ubara, Kenmei Takaichi, Tadao Akizawa, Takashi Akiba, Shunichi Fukuhara, Ronald L. Pisoni, Akira Saito, Bruce M. Robinson  Kidney International  Volume 92, Issue 2, Pages 497-503 (August 2017) DOI: 10.1016/j.kint.2017.02.008 Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 1 Hemoglobin A1c (HbA1c) levels in diabetic patients for different phases of the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). Sample: diabetic patients with HbA1c levels as reported at enrollment in JDOPPS phases 2 to 5 (2002–2015), N = 2300. Kidney International 2017 92, 497-503DOI: (10.1016/j.kint.2017.02.008) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 2 Estimated hazard ratios of mortality with hemoglobin A1c (HbA1c) categories in the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS) diabetic population (2002–2015). Sample: diabetic patients with HbA1c levels as reported at enrollment in JDOPPS phases 2 to 5 (2002–2015), N = 2300. Unadjusted model: stratified by phase, with facility clustering taken into account. Adjusted model: additionally adjusted for age, sex, dialysis vintage, 12 comorbidities, hemoglobin, albumin and creatinine levels, and insulin use. Kidney International 2017 92, 497-503DOI: (10.1016/j.kint.2017.02.008) Copyright © 2017 International Society of Nephrology Terms and Conditions